Genotyping of Mycobacterium tuberculosis using whole genome sequencing

. 2018 Sep ; 63 (5) : 537-545. [epub] 20180317

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid29550921

Grantová podpora
LO1503 Ministry of Education, Youth and Sports of the Czech Republic
Q39 Charles University Research Fund PROGRES

Odkazy

PubMed 29550921
DOI 10.1007/s12223-018-0599-y
PII: 10.1007/s12223-018-0599-y
Knihovny.cz E-zdroje

Tuberculosis (TB) is considered one of the most serious infectious diseases worldwide. Effective control of tuberculosis infection involves multiple steps, such as reliable detection, treatment, an epidemiological control as a part of case management, and further surveillance and monitoring of TB spread in the human population. Due to the accelerating advances in molecular biology, especially in DNA sequencing, in the past decade, the application of these methods has become crucial for TB evolution studies, differentiation of Mycobacterium tuberculosis genotypes, and their distribution. Currently, several molecular genetic methods are available. The oldest typing methods (e.g., IS6110-RFLP, spoligotyping, and MIRU-VNTR) can discover the chain of transmission to the patient. Currently, whole genome sequencing facilitates is furthermore able to identify the source of infection, the transmission trays among individuals sharing the same isolate, as well as determination of the TB evolution and its resistance to antituberculotic agents. It is obvious that this technique will become a new gold standard in genotyping methods in tuberculosis molecular epidemiological studies. In this article, molecular genetic typing methods with a special focus on whole genome sequencing and data management are reviewed.

Zobrazit více v PubMed

Braz J Microbiol. 2014 Aug 29;45(2):657-60 PubMed

Future Microbiol. 2011 Feb;6(2):203-16 PubMed

N Engl J Med. 2011 Feb 24;364(8):730-9 PubMed

Nucleic Acids Res. 2006 Jan 1;34(Database issue):D32-6 PubMed

J Clin Microbiol. 1993 Feb;31(2):406-9 PubMed

Bioinformation. 2011;6(7):283-5 PubMed

Antimicrob Agents Chemother. 2002 Feb;46(2):267-74 PubMed

Lancet. 1993 Mar 13;341(8846):647-50 PubMed

BMC Microbiol. 2006 Mar 06;6:23 PubMed

J Clin Microbiol. 2010 Apr;48(4):1422-4 PubMed

PLoS Pathog. 2005 Sep;1(1):e5 PubMed

Microbiology. 2002 Oct;148(Pt 10):2967-73 PubMed

Ther Adv Infect Dis. 2016 Apr;3(2):47-62 PubMed

Tuberculosis (Edinb). 2014 Jul;94(4):434-40 PubMed

Lancet Infect Dis. 2007 May;7(5):328-37 PubMed

Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2091-4 PubMed

J Clin Microbiol. 1997 Apr;35(4):907-14 PubMed

Rev Salud Publica (Bogota). 2010 Jun;12(3):510-21 PubMed

Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74 PubMed

J Korean Med Sci. 2016 Nov;31(11):1673-1683 PubMed

Indian J Med Res. 2015 Jun;141(6):761-74 PubMed

Biomedica. 2004 Jun;24 Supp 1:188-201 PubMed

Emerg Infect Dis. 2012 Apr;18(4):653-5 PubMed

Tuber Lung Dis. 1999;79(4):267-71 PubMed

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3684-9 PubMed

Crit Rev Microbiol. 2016 Sep;42(5):738-58 PubMed

J Clin Microbiol. 2001 Oct;39(10):3563-71 PubMed

J Appl Microbiol. 2003;94(5):781-91 PubMed

Mol Cell Probes. 1991 Feb;5(1):73-80 PubMed

Novartis Found Symp. 1998;217:160-72; discussion 172-7 PubMed

Infect Genet Evol. 2012 Jun;12(4):755-66 PubMed

J Med Microbiol. 2010 Mar;59(Pt 3):285-94 PubMed

PLoS Pathog. 2008 Sep 19;4(9):e1000160 PubMed

Biomed Res Int. 2014;2014:645802 PubMed

Int J Tuberc Lung Dis. 2000 Dec;4(12):1111-9 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...